Browse > Article

Changes of immunostimulatory effects by Immu-Forte on mice  

Jung, Ji-Youn (College of Veterinary Medicine, Seoul National University)
Publication Information
Korean Journal of Veterinary Research / v.45, no.4, 2005 , pp. 501-505 More about this Journal
Abstract
Immu-Forte composed of chitosan, ${\beta}-glucan$, manno-oligosaccharide and pangamic acid was evaluated for its effectiveness as a nonspecific immunostimulator in mice. The effects of Immu-Forte were determined by analysis of cytokines using ELISA and phenotype of leukocyte subpopulations using monoclonal antibodies specific to mouse leukocyte differentiation antigens and flow cytometry. All T cells, all B cells, CD4 T cells, CD8 T cells, macrophages, IL-2, IL-4, IL-12 and IFN-r in Immu-Forte A-treated group increased in 1 months posttreatment and were significantly higher (p < 0.05) than that of control at 1 months posttreatment. All T cells, all B cells, CD4 T cells, CD8 T cells, macrophages and IL-2 in Immu-Forte EX-treated low and middle dose groups increased in 1 months posttreatment and were significantly higher (p < 0.05) than that of control at 1 months posttreatment. In the Immu-Forte soybean-treated group, NK cells and IL-4 were significantly higher in middle dose-treated group, and IL-2, IL-4 and IFN-r were significantly higher in low dose-treated group. In the Immu-Forte F-treated group, all T cells, all B cells, CD4 T cells, CD8 T cells, macrophages, NK cells, IL-2, IL-4, IL-12 and IFN-r in high dose-treated group and all T cells, all B cells, CD4 T cells, CD8 T cells, macrophages, IL-2, IL-4, IL-12 and IFN-r in middle dose-treated group and NK cells, IL-2, IL-4, IL-12 and IFN-r in low dose-treated group were significantly higher (p < 0.05) than that of control at 1 months posttreatment. In conclusion, this study has demonstrated that Immu-Forte had an immunostimulatory effect on mice through proliferation and activation of mouse immune cells.
Keywords
cytokines; Immu-Forte; leukocyte; nonspecific immunostimulator;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Berg RD. Probiotics, prebiotics or conbiotics, Treands Microbiol 1998, 6, 89-92   DOI   PUBMED   ScienceOn
2 Bonneau M, Laarveld B. Biotechnology in animal nutrition, physiology and health. Livest Prod Sci 1999, 59, 223-241   DOI   ScienceOn
3 Anadon A, Martinez-Larranaga MR. Residues of antimicrobial drugs and feed additives in animal products; regulatory aspects. Livest Prod Sci 1999, 59, 183-198   DOI   ScienceOn
4 Pedersen KB, Aarestrup FM, Jensen NE, Bager F, Jensen LB, Jorsal SE, Nielsen TK, Hansen HC, Meyling A, Wegener HC. The need for a veterinary antibiotic policy. Vet Rec 1999, 145, 50-53
5 Hart T, Lamont A, Williams D. New drug targets in inflamation and immunomodulation. Drug Discov Today 1998, 3, 516-521   DOI   ScienceOn
6 Dutton RW, Bradley LM, Swain SL. T cell memory. Annu Rev Immunol 1998, 16, 201-223   DOI   ScienceOn
7 Gonser S, Weber E, Folkers G. Peptides and polypeptides as modulators of the immune reesponse : thymopentin-an example with unknown mode of action. Pharm Acta Helv 1999, 73, 265-273   DOI   ScienceOn